CEO Dr. Carl Schwartz and Richard Gabriel of Precision Therapeutics Inc. (NASDAQ: AIPT), join the show to talk in detail about the state of the recent merger, new technology for tumor and cancer testing, and plans for 2019. |
The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.